Cargando…

Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model

The hormone fibroblast growth factor 23 (FGF23) is secreted from bone and is involved in phosphorus (P) metabolism. FGF23 mainly binds the FGF receptor, which interacts with αKlotho in the kidney or parathyroid and regulates Na-dependent phosphate co-transporter type IIa (NaPi-IIa) and type IIc (NaP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugiura, Hidekazu, Matsushita, Ai, Futaya, Mayuko, Teraoka, Atsuko, Akiyama, Ken-ichi, Usui, Noriyoshi, Nagano, Nobuo, Nitta, Kosaku, Tsuchiya, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843171/ https://www.ncbi.nlm.nih.gov/pubmed/29518087 http://dx.doi.org/10.1371/journal.pone.0191706

Ejemplares similares

Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
por: Nitta, Kosaku
Publicado: (2010)

Management of Osteoporosis in Chronic Kidney Disease
por: Nitta, Kosaku, et al.
Publicado: (2017)

Germline Mutations for Kidney Volume in ADPKD
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

A case of pulmonary dialysis-related amyloidosis with reticular opacity of the lung in a patient undergoing long-term dialysis
por: Sugiura, Hidekazu, et al.
Publicado: (2011)

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
por: Yamazaki, Mayuko, et al.
Publicado: (2019)

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Sphingosine‐1‐phosphate acts as a key molecule in the direct mediation of renal fibrosis
por: Shiohira, Shunji, et al.
Publicado: (2013)

Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
por: Kamei, Daigo, et al.
Publicado: (2020)

Five cases of tonsillectomy and steroid pulse therapy for recurrent immunoglobulin A nephropathy after kidney transplantation
por: Hoshino, Yoshie, et al.
Publicado: (2013)

Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis
por: Nishizawa, Yoko, et al.
Publicado: (2020)

Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease
por: Nitta, Kosaku
Publicado: (2010)

A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib
por: Karasawa, Kazunori, et al.
Publicado: (2023)

Long-term effects of contrast media exposure on renal failure progression: a retrospective cohort study
por: Takura, Tomoyuki, et al.
Publicado: (2023)

Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series
por: Usui, Ryosuke, et al.
Publicado: (2018)

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE
por: Wolf, Myles
Publicado: (2012)

Visceral fat and attribute-based medicine in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2023)

New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
por: Mace, Maria L., et al.
Publicado: (2020)

Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Role of fibroblast growth factor 23 in patients with chronic kidney disease
por: Wang, Song-Yan, et al.
Publicado: (2021)

Research progress of fibroblast growth factor 23 in acute kidney injury
por: Zhang, Lina, et al.
Publicado: (2022)

The Importance of Phosphate Control in Chronic Kidney Disease
por: Tsuchiya, Ken, et al.
Publicado: (2021)

New Insight into Atherosclerosis in Hemodialysis Patients: Overexpression of Scavenger Receptor and Macrophage Colony-Stimulating Factor Genes
por: Nishida, Miki, et al.
Publicado: (2016)

Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients
por: Kamei, Yuiko, et al.
Publicado: (2018)

Denosumab Recovers Aortic Arch Calcification During Long-Term Hemodialysis
por: Suzuki, Shunji, et al.
Publicado: (2020)

Interstitial fibroblasts in donor kidneys predict late posttransplant anemia
por: Mafune Hamada, Aki, et al.
Publicado: (2019)

Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease
por: Michon-Colin, Arthur, et al.
Publicado: (2023)

25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up
por: Ishigami, Junichi, et al.
Publicado: (2021)

Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation
por: Nakano, Toshihiro, et al.
Publicado: (2019)

Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2022)

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study
por: Sato, Masayo, et al.
Publicado: (2020)

Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis
por: Honda, Hirokazu, et al.
Publicado: (2017)

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

The association of indoxyl sulfate with fibroblast growth factor‐23 in cats with chronic kidney disease
por: Liao, Yu‐Lun, et al.
Publicado: (2019)

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019)

Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
por: El Ters, Mireille, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7aumb72n471avs1t0o7a5t6o4p